Brygida Berse, PhD
Adjunct Research Assistant Professor
Boston University School of Medicine
Dept of Pathology & Laboratory Medicine
Other Pathology Section

MSc, Warsaw University
PhD, Warsaw University



Field of study: Molecular Biology/Neuroscience
Expertise: gene expression; signal transduction; cholinergic biology.

Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Division of Graduate Medical Sciences


Bedford VA - Edith Nourse Rogers Memorial VA Hosp



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Efimova O, Berse B, Denhalter DW, DuVall SL, Filipski KK, Icardi M, Kelley MJ, Lynch JA. Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration. BMC Med Inform Decis Mak. 2017 May 30; 17(1):71. PMID: 28558785.
  2. Lynch JA, Berse B, Coomer N, Kautter J. 21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010-2013. Genet Med. 2017 Mar 23. PMID: 28333918; DOI: 10.1038/gim.2017.19;.
  3. Lynch JA, Berse B, Dotson WD, Khoury MJ, Coomer N, Kautter J. Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data. Genet Med. 2017 Jan 26. PMID: 28125086; DOI: 10.1038/gim.2016.209;.
  4. Chun DS, Berse B, Venne VL, DuVall SL, Filipski KK, Kelley MJ, Meyer LJ, Icardi MS, Lynch JA. BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines. Fam Cancer. 2017 Jan; 16(1):41-49. PMID: 27589855; DOI: 10.1007/s10689-016-9921-5;.
  5. Lynch JA, Berse B, Chun D, Rivera D, Filipski KK, Kulich S, Viernes B, DuVall SL, Kelley MJ. Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs. Clin Lung Cancer. 2017 Jul; 18(4):401-409. PMID: 28038980; DOI: 10.1016/j.cllc.2016.11.018;.
  6. Lynch J, DuVall SL, Berse B, Whatley A, St Pierre C, Oloruntoba O, Hunt CM. Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013. Mil Med. 2016 Oct; 181(10):1375-1381. PMID: 27753578.
  7. Lynch J, Berse B. Methods to identify BRCA testing in claims data. Am J Obstet Gynecol. 2016 Jul; 215(1):133-4. PMID: 27083760; DOI: 10.1016/j.ajog.2016.03.049;.
  8. Lynch JA, Berse B, Petkov V, Filipski K, Zhou Y, Khoury MJ, Hassett M, Freedman AN. Implementation of the 21-gene recurrence score test in the United States in 2011. Genet Med. 2016 Oct; 18(10):982-90. PMID: 26890451; DOI: 10.1038/gim.2015.218;.
  9. Lynch JA, Venne V, Berse B. Genetic tests to identify risk for breast cancer. Semin Oncol Nurs. 2015 May; 31(2):100-7. PMID: 25951739; PMCID: PMC4998965; DOI: 10.1016/j.soncn.2015.02.007;.
  10. Berse B, Lynch JA. Molecular diagnostic testing in breast cancer. Semin Oncol Nurs. 2015 May; 31(2):108-21. PMID: 25951740; DOI: 10.1016/j.soncn.2015.02.008;.
Showing 10 of 60 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 60 publications over 21 distinct years, with a maximum of 11 publications in 1995

YearPublications
19831
19862
19911
19925
19934
19945
199511
19962
19972
19981
19992
20004
20022
20042
20053
20061
20071
20081
20152
20164
20174
Contact for Mentoring:


200 Springs Rd
Bedford MA 01730
Google Map


Berse's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_